Page last updated: 2024-10-31

mitotane and Anasarca

mitotane has been researched along with Anasarca in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research Excerpts

ExcerptRelevanceReference
"Mitotane chemotherapy is a standard but unproven adjuvant treatment that is associated with many complications, and its induction of hepatic CYP 3A4 enzymes necessitates adjustment of other medications."1.72Massive adrenocortical carcinoma presenting as peripheral edema: a case report. ( Goodkin, DA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Goodkin, DA1

Other Studies

1 other study available for mitotane and Anasarca

ArticleYear
Massive adrenocortical carcinoma presenting as peripheral edema: a case report.
    Journal of medical case reports, 2022, Jun-20, Volume: 16, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Edema; Humans; Hydrocortisone; Male; Mitot

2022